Reply
Authors:
- Dean J. KereiakesDKDean J. Kereiakes
- Richard E. KuntzRKRichard E. Kuntz
- Laura MauriLMLaura Mauri
- Mitchell W. KrucoffMKMitchell W. Krucoff
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent ComparisonCirculation, 2005
- Surrogates, substudies, and real clinical end points in trials of drug-eluting stents**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2005
- Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent RestenosisJAMA, 2005